Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

1. Case Report: Expanding the diagnostic spectrum of non-invasive prenatal testing to structural chromosomal abnormalities.Frontiers in genetics · 2026
   Article
2. Next generation sequencing and beyond: a review of genomic sequencing methods.Functional & integrative genomics · 2025
   Article
3. CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice.Science translational medicine · 2025
   Article
4. Intersection of the fragile X-related disorders and the DNA damage response.DNA repair · 2024
   Review
5. Deciphering novel TCF4-driven mechanisms underlying a common triplet repeat expansion-mediated disease.PLoS genetics · 2024
   Article
6. The fragile X locus is prone to spontaneous DNA damage that is preferentially repaired by nonhomologous end-joining to preserve genome integrity.iScience · 2024
   Article
7. Editorial for the Fragile X Syndrome Genetics Special Issue: May 2023.Genes · 2023
   Article
8. Emerging roles of i-motif in gene expression and disease treatment.Frontiers in pharmacology · 2023
   Review
9. New Animal Models for Understanding FMRP Functions and FXS Pathology.Cells · 2022
   Review
10. 341 Repeats Is Not Enough for Methylation in a New Fragile X Mouse Model.eNeuro
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as